391 related articles for article (PubMed ID: 9070252)
1. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A
Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252
[TBL] [Abstract][Full Text] [Related]
2. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
[TBL] [Abstract][Full Text] [Related]
3. Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase.
Deutsch DG; Omeir R; Arreaza G; Salehani D; Prestwich GD; Huang Z; Howlett A
Biochem Pharmacol; 1997 Feb; 53(3):255-60. PubMed ID: 9065728
[TBL] [Abstract][Full Text] [Related]
4. Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide.
Arizzi MN; Cervone KM; Aberman JE; Betz A; Liu Q; Lin S; Makriyannis A; Salamone JD
Life Sci; 2004 Jan; 74(8):1001-11. PubMed ID: 14672756
[TBL] [Abstract][Full Text] [Related]
5. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs.
Adams IB; Ryan W; Singer M; Thomas BF; Compton DR; Razdan RK; Martin BR
J Pharmacol Exp Ther; 1995 Jun; 273(3):1172-81. PubMed ID: 7791088
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.
Brizzi A; Brizzi V; Cascio MG; Bisogno T; Sirianni R; Di Marzo V
J Med Chem; 2005 Nov; 48(23):7343-50. PubMed ID: 16279794
[TBL] [Abstract][Full Text] [Related]
8. A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
Ueda N; Goparaju SK; Katayama K; Kurahashi Y; Suzuki H; Yamamoto S
J Med Invest; 1998 Aug; 45(1-4):27-36. PubMed ID: 9864962
[TBL] [Abstract][Full Text] [Related]
9. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
[TBL] [Abstract][Full Text] [Related]
10. The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors.
Edgemond WS; Campbell WB; Hillard CJ
Prostaglandins Leukot Essent Fatty Acids; 1995; 52(2-3):83-6. PubMed ID: 7784462
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.
López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Fowler CJ; Tiger G; de Lago E; Fernández-Ruiz J; Ramos JA
J Med Chem; 2003 Apr; 46(8):1512-22. PubMed ID: 12672252
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of arachidonoyl ethanolamide hydrolysis.
Koutek B; Prestwich GD; Howlett AC; Chin SA; Salehani D; Akhavan N; Deutsch DG
J Biol Chem; 1994 Sep; 269(37):22937-40. PubMed ID: 8083191
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid properties of methylfluorophosphonate analogs.
Martin BR; Beletskaya I; Patrick G; Jefferson R; Winckler R; Deutsch DG; Di Marzo V; Dasse O; Mahadevan A; Razdan RK
J Pharmacol Exp Ther; 2000 Sep; 294(3):1209-18. PubMed ID: 10945879
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374).
Gifford AN; Bruneus M; Lin S; Goutopoulos A; Makriyannis A; Volkow ND; Gatley SJ
Eur J Pharmacol; 1999 Oct; 383(1):9-14. PubMed ID: 10556675
[TBL] [Abstract][Full Text] [Related]
15. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
[TBL] [Abstract][Full Text] [Related]
16. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase.
van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M
J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944
[TBL] [Abstract][Full Text] [Related]
17. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.
Gubellini P; Picconi B; Bari M; Battista N; Calabresi P; Centonze D; Bernardi G; Finazzi-Agrò A; Maccarrone M
J Neurosci; 2002 Aug; 22(16):6900-7. PubMed ID: 12177188
[TBL] [Abstract][Full Text] [Related]
18. Biochemistry of the endogenous ligands of cannabinoid receptors.
Di Marzo V; Deutsch DG
Neurobiol Dis; 1998 Dec; 5(6 Pt B):386-404. PubMed ID: 9974173
[TBL] [Abstract][Full Text] [Related]
19. Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects.
Wiley JL; Dewey MA; Jefferson RG; Winckler RL; Bridgen DT; Willoughby KA; Martin BR
Life Sci; 2000 Aug; 67(13):1573-83. PubMed ID: 10983852
[TBL] [Abstract][Full Text] [Related]
20. The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period.
Paria BC; Deutsch DD; Dey SK
Mol Reprod Dev; 1996 Oct; 45(2):183-92. PubMed ID: 8914076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
